The data analytics giant Palantir is living a double life these days. On one side, CEO Alex Karp is stirring up a geopolitical storm with his hawkish manifesto; on the other, the company’s commercial engine is firing on all cylinders. On Wednesday, the stock punched through the $150 mark for the first time in weeks, closing up roughly 4.6% at $152.68, as investors chose to focus on the numbers rather than the noise.
The rally wasn’t just speculative froth. Palantir’s US commercial business now boasts a remaining contract value of $4.38 billion — a staggering 145% jump from a year ago. That pipeline of future revenue is the kind of metric that gets institutional buyers interested, and it helps explain why the stock was one of the most heavily traded names in the software sector, with around 43 million shares changing hands by midday. The broader software index managed a mere 1.22% gain on the same day.
Management’s forward guidance adds further heft to the bull case. For fiscal 2026, the company is targeting revenue in the range of $7.18 billion to $7.20 billion, implying growth of roughly 61%. That kind of expansion is rare even in high-growth tech, and it’s reflected in Palantir’s eye-popping “Rule of 40” score of 127%. In enterprise software, anything above 40 is considered healthy; Palantir’s figure is in a league of its own.
The commercial strength is being bolstered by fresh government contracts. On April 22, the US Department of Agriculture signed a $300 million framework agreement with Palantir to modernize its supply chain operations. Meanwhile, the company’s Artificial Intelligence Platform (AIP) has been integrated with xAI’s “Grok 4.20” models since April, deepening its technological moat. Profitability is also on an upward trajectory — the adjusted operating margin hit a record 57.4% in the final quarter of 2025.
Should investors sell immediately? Or is it worth buying Palantir?
Yet the political backdrop is far from serene. On April 21, Palantir published a summary of Karp’s book “The Technological Republic,” in which he calls for mandatory national service in the US and an accelerated AI arms race. The manifesto has drawn sharp condemnation from British parliamentarians, who labeled the vision “dystopian” on Wednesday. Some are now calling for a review of Palantir’s existing contracts with the UK government, which include sensitive data management for the NHS and the Ministry of Defence.
The clash between Karp’s ideological positioning and the company’s operational reality has created a volatile trading environment. On a euro-denominated basis, the stock sits at around €128.58, roughly 9% below its 200-day moving average. Over the past week, the shares have recovered about 7%, but they remain nearly 10% in the red year-to-date. The 52-week high of €179.86 looks distant for now.
Analyst sentiment reflects the uncertainty. Mizuho recently trimmed its price target to $185, though the consensus target still stands at $197.32 with a “Moderate Buy” rating. The forward price-to-earnings ratio of roughly 111 underscores just how much growth is already priced in. Bulls argue that Palantir’s capital efficiency justifies the premium; bears point to the political headwinds and the risk of contract scrutiny in key markets like the UK.
All eyes now turn to May 4, when Palantir reports first-quarter 2026 results after the US market close. The Street expects normalized earnings of $0.28 per share. The subsequent webcast will be more than just a numbers call — management will need to address how Karp’s aggressive geopolitical stance is affecting the stability of international contracts. For now, the $4.38 billion pipeline offers a powerful counter-narrative to the political drama.
Ad
Palantir Stock: Buy or Sell?! New Palantir Analysis from April 23 delivers the answer:
The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 23.
Palantir: Buy or sell? Read more here...











